GulfPCR-GIM 2025

11 Dec 2025

TAVI Stents, scaffolds and DCB

Beyond the horizon - Shaping the future of cardiology through meaningful innovation in structural heart and coronary - LIVE Case

Sponsored by Meril

Operators: H. Noor, S. Shivappa

Procedural Analyst: J. Michel

SHOW MORE

Summary

This live case–based session explores how innovation is shaping structural heart and coronary interventions.

A real-time TAVI case in a degenerated aortic valve highlights pre-procedural imaging, sizing strategies, procedural decision-making, and post-procedural care.

The session also reviews ongoing and upcoming Myval THV trials, showing how new technologies impact real-world outcomes.

Finally, it examines ultra-thin strut drug-eluting stents and their clinical benefits, including insights from the SORT OUT XII trial, offering a forward-looking view of daily practice in structural and coronary cardiology.

Learning Objectives

To learn from the experts best-in-the-class TAVI practice: pre-procedural (imaging, sizingrationale, treatment strategy), procedural tips and tricks, post-procedural management
To appreciate the impact of the novel Myval THV series via real world case scenarios
To understand relevance of ultra thin strut drug-eluting stent platform and its clinicalbenefits

Speaker

Welcome and session objectives

Download presentation

Speaker

Operator strategy

Download presentation

Speaker

Ongoing and upcoming trials for Myval THV series

Download presentation

Speaker

Ultra thin strut drug-eluting stent platform, its importance and update on SORT OUT Xll trial

Download presentation